Form 8-K - Current report:
SEC Accession No. 0001193125-11-036319
Filing Date
2011-02-15
Accepted
2011-02-15 09:45:38
Documents
3
Period of Report
2011-02-15
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d8k.htm 8-K 15439
2 PRESS RELEASE dex991.htm EX-99.1 117670
3 GRAPHIC g151646g75x66.jpg GRAPHIC 13066
  Complete submission text file 0001193125-11-036319.txt   152831
Mailing Address 11085 NORTH TORREY PINES ROAD SUITE 300 LA JOLLA CA 92037
Business Address 11085 NORTH TORREY PINES ROAD SUITE 300 LA JOLLA CA 92037 858-550-7500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

EIN.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33093 | Film No.: 11612631
SIC: 2834 Pharmaceutical Preparations